PanACEA-MAMS-TB-01
B1171003
B1171002
B1171001
Effect of PA-824 and PA-824 plus Moxifloxacin on the QTc Interval in Health Volunteers
ACTG 5306 Phase I, Three-Arm Safety, Tolerability, and Pharmacokinetic Interaction Study of PA-824, an Investigational Nitroimidazole for the Treatment of Tuberculosis, Together With Efavirenz, Ritona
Evaluation of Early Bactericidal Activity in Pulmonary Tuberculosis
Traitement du Sida
Phase 1 Effect of PA-824 and PA-824 plus Moxifloxacin on the QTc Interval in Health Volunteers
Pages
